September 1, 2002The Journal of Clinical Endocrinology & Metabolism

Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

View Full Paper

Ask AI

Bookmark

Early multidisciplinary management optimizes clinical outcomes for infants with 21-hydroxylase deficiency while minimizing excess glucocorticoid exposure.
Prenatal dexamethasone eliminates genital virilization in more than 85% of affected female fetuses, although comprehensive long-term safety remains unproven.
Consensus statement formulated by forty international experts establishes standard diagnostic criteria and hormonal therapies for congenital adrenal hyperplasia.
Highlights the necessity of newborn blood-spot 17-hydroxyprogesterone screening to reduce infant mortality and calls for structured long-term outcome registries.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Consensus statement reports optimal diagnostic and therapeutic strategies for 21-hydroxylase deficiency in infants, highlighting coordinated multidisciplinary care.

Cite This Study

A 2002 study studied this question.

synapsesocial.com/papers/6a8e599a7564567bef28dac8 https://doi.org/10.1210/jc.2002-020611

View Full Paper

Ask AI

Bookmark

Implication

Consensus statement reports optimal diagnostic and therapeutic strategies for 21-hydroxylase deficiency in infants, highlighting coordinated multidisciplinary care.

Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

Key Points

Discussion

Implication

Cite This Study

Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider